Loading stock data…
OMDA
$18.32+0.44 (+2.46%)
After Hours$18.34+0.02 (+0.12%)· Last close Jun 9
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Omada Health, Inc. in the Healthcare sector is trading at $18.32 with a market capitalization of $1.0B. Wall Street consensus targets $22.92 (12 analysts), implying a +25.1% move over the next 12 months. The stock is currently 32% below its 52-week high of $26.91, remaining 5.0% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +25.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$18.32
Potential Downside
0%
Whystock Fair Value$18.32
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus12 analysts
Buy
Mean target$22.92+25.1%
Range$15.00 – $30.00
Fundamentals
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to ad...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.03B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-2.69%
Volume
Today's trading volume
901,389
Recent News
Three Stocks That May Be Trading Below Estimated Value In May 2026
The United States market has shown robust growth, with a 1.8% increase over the last week and a remarkable 28% rise over the past year, while earnings are projected to grow by 17% annually. In such an environment, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for capitalizing on future growth.
What to Know About This Fund's $13.9 Million Exit From a Skyrocketing AI Power Play
Babcock & Wilcox delivers energy and emissions control solutions to industrial and utility clients worldwide.
Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growth
Oceaneering International delivers subsea robotics, engineered products, and digital solutions to global energy and defense clients.
What to Know About This Fund's $9 Million Exit From a Pawn Shop Giant Up Nearly 150% This Past Year
EZCORP operates a broad network of pawn stores and digital platforms, serving consumers seeking short-term credit and value-priced goods.
How This Eli Lilly-Tied IPO Stock Fared In Its First Quarter
IPO stock Omada Health easily beat first-quarter sales views Thursday, and announced a deal with drug titan Eli Lilly. But shares fell Friday.